ライフサイエンスコーパス: postoperative nausea

1 y to experience adverse side-effects such as postoperative nausea.

2 r the prevention of chemotherapy-induced and postoperative nausea and vomiting (CINV and PONV).

3 delivery, but is frequently associated with postoperative nausea and vomiting (PONV) and pruritus.

4 Postoperative nausea and vomiting (PONV) continues to be

5 amethasone given before thyroidectomy reduce postoperative nausea and vomiting (PONV) in a randomized

6 eoperative thirst, amount of fluid ingested, postoperative nausea and vomiting (PONV), and administra

7 ncrease the risk of postoperative infection, postoperative nausea and vomiting (PONV), or other compl

8 : The purpose of this review is to highlight postoperative nausea and vomiting (PONV), to discuss why

9 ith known comorbidities including migraines, postoperative nausea and vomiting (PONV), vertigo and mo

10 f 5mg/day, the current dose for treatment of postoperative nausea and vomiting (PONV).

11 g conditions, various measures of awakening, postoperative nausea and vomiting and discharge from the

12 rd for treatment of chemotherapy-induced and postoperative nausea and vomiting and have potential for

13 armamentarium available to treat and prevent postoperative nausea and vomiting continues to expand.

14 Postoperative nausea and vomiting in the first 24 hours

15 ost successful approach to the prevention of postoperative nausea and vomiting is multimodal, with co

16 The cost-effectiveness of such screening in postoperative nausea and vomiting management has, howeve

17 rioperative administration of droperidol for postoperative nausea and vomiting on the basis of the po

18 ng patients include female sex, a history of postoperative nausea and vomiting or motion sickness, yo

19 Common variables that identify high-risk postoperative nausea and vomiting patients include femal

20 nse with reference to emergence delirium and postoperative nausea and vomiting prevention to outline

21 drugs, both new and old, and their impact on postoperative nausea and vomiting prophylaxis and treatm

22 algesia, postoperative multimodal analgesia, postoperative nausea and vomiting prophylaxis, early die

23 Routine regional anesthesia use, multimodal postoperative nausea and vomiting prophylaxis, multimoda

24 We also discuss 'multimodalities' addressing postoperative nausea and vomiting prophylaxis, periopera

25 based anesthesia satisfaction data, limiting postoperative nausea and vomiting remains a major patien

26 mal strategy for prevention and treatment of postoperative nausea and vomiting remains uncertain.

27 miting, new clinical studies provide revised postoperative nausea and vomiting risk prediction tools,

28 Combined anesthesia decreased postoperative nausea and vomiting risk without affecting

29 ge of stool), prolonged postoperative ileus, postoperative nausea and vomiting score, Overall Benefit

30 Postoperative nausea and vomiting was reported in 48 pat

31 Notably, postoperative nausea and vomiting were significantly red

32 Given the multifactorial nature of postoperative nausea and vomiting, a multimodal approach

33 pression, atelectasis, pneumonia, ileus, and postoperative nausea and vomiting, and also improved rec

34 procedures of the breast and axilla, reduces postoperative nausea and vomiting, and provides prolonge

35 dle ear surgery leads to a high incidence of postoperative nausea and vomiting, and these are best ma

36 r antagonists has improved the management of postoperative nausea and vomiting, but has not completel

37 ement, intraoperative awareness with recall, postoperative nausea and vomiting, medical complications

38 preventing or rapidly rescuing patients from postoperative nausea and vomiting, new clinical studies

39 d nonopioid analgesia, and the incidences of postoperative nausea and vomiting, oculocardiac events,

40 There remains a finite incidence of postoperative nausea and vomiting, particularly among hi

41 This review complements data on postoperative nausea and vomiting, suggesting a biologic

42 that this drug does reduce the incidence of postoperative nausea and vomiting, with somewhat delayed

43 ensive alternative medications used to treat postoperative nausea and vomiting.

44 from clinical practice for the indication of postoperative nausea and vomiting.

45 nd their potential role in the management of postoperative nausea and vomiting.

46 re included for management and prevention of postoperative nausea and vomiting.

47 onists and the impact of pharmacogenetics on postoperative nausea and vomiting.

48 sia, and percentage of patients experiencing postoperative nausea and vomiting.

49 children undergoing tonsillectomy to reduce postoperative nausea and vomiting; however, they might i

50 d pressure, weight management, dysmenorrhea, postoperative nausea, and chemotherapy-induced vomiting

51 postoperative complications, operative time, postoperative nausea, length of hospital stay, recurrenc

52 creening Tool (MST) score, 3-d food records, postoperative nausea, LOS, and complications.

53 Dexamethasone is effective in preventing postoperative nausea without increased risk of bleeding.